Musk 'was going to hit me,' OpenAI executive says at trial

Greg Brockman testified that Elon Musk physically threatened him in a 2017 confrontation and said Musk sought absolute control of OpenAI before leaving. The case centers on Musk's claim that OpenAI abandoned its nonprofit mission and misused his $38 million donation, while OpenAI argues Musk exited voluntarily and later became a direct competitor through xAI. Brockman said OpenAI now spends about $50 billion a year on compute versus $30 million in 2017, underscoring the capital intensity of AI development.

Analysis

The key market takeaway is not the courtroom theater; it is the widening gap between AI capex intensity and the governance optics around who controls the economic rents. If the dispute keeps framing OpenAI as a quasi-public mission that migrated into a tightly controlled commercial engine, it strengthens the case that frontier AI is becoming a winner-take-most platform where access to compute and capital matter more than legacy founder narratives. That dynamic is mildly negative for TSLA because it keeps Musk’s attention split while reinforcing the market’s perception that xAI is a strategic but still secondary asset versus Tesla’s core industrial franchise.

For TSLA, the second-order risk is reputational and managerial: prolonged litigation increases headline volatility and invites renewed scrutiny of Musk’s governance style across all his companies. In the near term, this is more about multiple compression than fundamental earnings damage, but if the trial surfaces documents suggesting Musk was aware of OpenAI’s commercialization path earlier than his complaint implies, that weakens any legal leverage and makes the lawsuit look more like competitive posturing than a shareholder-protective action. That outcome would likely cap the probability of any litigation-driven downside in Tesla; the bigger TSLA risk is simply distraction and the market demanding a higher governance discount into year-end.

The counterpoint is that the market may be overpricing the direct relevance of this case to Tesla cash flows. Unless the trial expands into explicit claims touching Tesla AI talent, compute allocation, or xAI financing, the earnings impact is indirect and the stock may mean-revert after each headline burst. The real economic winner is likely the hyperscaler/compute ecosystem, because the testimony implicitly validates that frontier model development requires industrial-scale spend, which supports sustained demand for chips, networking, and cloud capacity regardless of the legal outcome.

The catalyst stack is binary over weeks, not days: Musk’s testimony and then Altman’s appearance can either intensify the narrative or re-center it on OpenAI’s scaling advantages. If the record shifts toward Musk having knowingly exited a commercialization plan, the lawsuit loses bite and TSLA’s litigation overhang should fade. If instead the trial exposes any governance missteps at OpenAI, expect a short-lived rebound in Musk-related sentiment, but not enough to alter Tesla’s medium-term operating thesis.

Key Decisions for Investors

• Maintain a tactical underweight in TSLA vs the Nasdaq for the next 2-6 weeks; use trial headlines as opportunities to short strength, with a stop if the case shifts toward clear Tesla-specific operational harm.
• If long AI infrastructure, stay long semis/cloud winners and hedge with a small TSLA short: the trial reinforces that frontier AI spend remains structurally high even as company-specific narratives churn.
• For event-driven accounts, consider a TSLA put spread into Altman's testimony window (1-3 weeks): limited premium outlay, benefit from renewed governance/attention risk if cross-examination turns adverse for Musk.
• Avoid overreacting to case headlines by selling TSLA core too aggressively; the litigation is a sentiment overhang, not a direct earnings inflection, unless new evidence ties Tesla resources to xAI.
• Relative-value trade: long NVDA / short TSLA into the next 30-45 days if you want exposure to AI capex without Musk-specific key-person and governance risk.